Prot# P05685: A Phase 3 Safety and Efficacy Study of Boceprevir in Combination with Peginterferon Alfa-2a and Ribavirin in Subject with Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment with Peginterferon/Ribavirin